Joel Brierre

Joel Brierre is the founder of KVI (Kaivalya Ventures Inc.), an ecosystem for discovering the unique potentials of 5-MeO-DMT, the world’s most powerful psychedelic. Joel and his team collaborate with some of the top universities and researchers in the world, executing groundbreaking studies to understand the neurological outcomes of this molecule, including the world’s first official EEG study of the 5-MeO peak experience. KVIs mission is to shepherd 5-MeO-DMT into the world in a safe and effective way. KVI is the parent company to Tandava, F.I.V.E., and Five Discovery. Together the subsidiaries cover integrative retreats, training and education, and drug discovery and development with non-hallucinogenic analogs. Joel and his co-founder Victoria Wueschner created the FIVE training which is recognized as the world’s leading training program for 5-MeO-DMT facilitation which has set a standard of care and excellence for others going forward. The Tandava Institute is located in Tepoztlán, Mexico and was the first of its kind, collecting Real World Evidence data through multi-day retreats and utilizing this data to further inform education, training, protocols, and novel drug discovery. Led by Dr. Manesh Girn, Five Discovery is creating novel, non-hallucinogenic compounds inspired by 5-MeO-DMT, treating brain health and CNS disorders.